Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

AstraZeneca enters into an agreement with Covis Pharma to sell its rights to Alvesco, Omnaris and Zetonna

CAMBRIDGE, 07-Nov-2018 — /EuropaWire/ — AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal symptoms associated with … Read the full press release

Empa and EPFL develop novel face mask for medical personnel with unobstructed view of the wearer’s facial expressions

Novel protective mask for medical personnel Dübendorf, Switzerland, 05-Nov-2018 — /EuropaWire/ — Laughter is the best medicine, says medical research. But how are patients supposed to feel like smiling if the faces of the nursing staff and even their beloved ones … Read the full press release

Brian Tyler to succeed John H. Hammergren as McKesson CEO

San Francisco, CA, USA, 05-Nov-2018 — /EuropaWire/ — McKesson Corporation (NYSE:MCK) today announced that John H. Hammergren, chairman and chief executive officer (CEO), has decided to retire, effective March 31, 2019. McKesson’s Board of Directors has unanimously selected Brian Tyler, … Read the full press release

ILC Dover to Open New Production Facility in Blarney, Ireland for Added Capabilities, Capacity and Jobs

Expansion positions ILC as leading single use powder handling solutions provider to the global pharma & biopharma market FREDERICA, DE, USA, 01-Nov-2018 — /EuropaWire/ — ILC Dover, a global leader in flexible containment solutions for the pharmaceutical and biopharmaceutical industry … Read the full press release

Novartis and Pfizer announce clinical development agreement for the treatment of NASH

Agreement includes a clinical trial to evaluate a combination of tropifexor (LJN452) and one or more Pfizer compounds for the treatment of non-alcoholic steatohepatitis (NASH) Novartis has a leading development portfolio in non-viral liver diseases, including NASH There are currently no … Read the full press release

SABCA: medical drone transport system project selected for funding from Smart Mobility Belgium

BRUSSELS/ANTWERP, 24-Oct-2018 — /EuropaWire/ — Helicus Aero Initiative (HAI) is putting in place a system that is able to transport medical parcels by drones between hospitals and their laboratories/pharmacies. The project, named MEDRONA, was selected for funding by the federal government. … Read the full press release

WPP appointed to support GSK Consumer Healthcare’s global Panadol business

LONDON, 19-Oct-2018 — /EuropaWire/ — Following a competitive pitch process, GSK Consumer Healthcare has appointed WPP to support its global Panadol business. WPP will be responsible for creating integrated creative campaigns and content across advertising, digital, shopper and expert marketing, PR … Read the full press release

Europe Home Diagnostics Market Driven by Burgeoning Glucose Monitoring Device Sales, Consumer Demand for Non-Invasive Kits Largely Unmet – Fact.MR Study

DUBLIN 2, Ireland, 18-Oct-2018 — /EuropaWire/ — The European home diagnostics industry is realigning to foster integration with the broader customer-centric healthcare services. Growing consumer preference for home-based diagnostics, combined with innovation in online platforms, is creating sustained opportunities in this … Read the full press release

Montagu to sell Nemera to Astorg

LONDON, 18-Oct-2018 — /EuropaWire/ — Montagu Private Equity (“Montagu”) and Astorg (“Astorg”) today announce that Montagu has signed an agreement to sell Nemera (“the company”), a leading global manufacturer of drug administration systems for the pharmaceutical industry, to Astorg. While … Read the full press release

STFC’s Central Laser Facility and York University used the ULTRA laser to develop a new technique to study chemical catalysts

SWINDON, 15-Oct-2018 — /EuropaWire/ — STFC’s world-leading Central Laser Facility (CLF) has been instrumental in new research which might see efficiency savings being made in an industry worth billions to the UK. Researchers from CLF and York University have used the ULTRA … Read the full press release

Sanofi completes the divestment of its European generics business Zentiva to Advent

PARIS, 04-Oct-2018 — /EuropaWire/ — Sanofi has completed the previously announced divestment of its European generics business Zentiva to Advent International (Advent) effective September 30. The transaction was finalized ahead of schedule for €1,9 billion (enterprise value). Sanofi announced the beginning … Read the full press release

Capgemini won a 2018 Systems Integrator Partner of the Year for Customer Impact award from Pivotal Software

PARIS, 28-Sep-2018 — /EuropaWire/ — Capgemini today announced that it has won a 2018 Systems Integrator Partner of the Year for Customer Impact award from Pivotal Software, Inc. Capgemini was honored with the prestigious award during SpringOne Platform in Washington, D.C for its work … Read the full press release

The European Medicines Agency to launch new version of its corporate website

Fresh design and improved features to provide better user experience LONDON, 25-Sep-2018 — /EuropaWire/ — The European Medicines Agency (EMA) will launch a new version of its corporate website (www.ema.europa.eu) on 27 September 2018. The new website will have an improved … Read the full press release

ZEISS presents its cross-platform ophthalmic digital portfolio at the ESCRS & EURETINA exhibition

During the combined exhibition of the European Society of Cataract & Refractive Surgeons (ESCRS) and the European Society of Retina Specialists (EURETINA), ZEISS presents its cross-platform ophthalmic digital portfolio which aids doctors in disease management, allowing them to help their … Read the full press release

New Study Reconfirms Effectiveness and Safety of Fotona Dynamis Laser Treatment for Minimally-Invasive Urinary Incontinence

LJUBLJANA, Slovenia, 21-Sep-2018 — /EuropaWire/ — The latest study published in the World Journal of Urology (Comparison between erbium‑doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence – https://doi.org/10.1007/s00345-018-2445-x) provides further … Read the full press release

Cambridge and Oxford researchers discovered new molecule that plays a key role in the immune response that is triggered by influenza infections

Researchers at the University of Cambridge and the University of Oxford have discovered a new molecule that plays a key role in the immune response that is triggered by influenza infections. The molecule, a so-called mini viral RNA, is capable … Read the full press release

Peter Goldschmidt succeeded Claudio Albrecht as the Chief Executive Officer of STADA Arzneimittel AG

Goldschmidt: “I look forward to working with the highly experienced team at STADA and continuing the Group’s long-term growth” Supervisory Board Chairman von Au: “Goldschmidt is the right man that STADA needs to ensure the Group successfully retains its strong … Read the full press release

Lundbeck begins clinical development of yet another potential new treatment of Parkinson’s disease

New treatment might have the potential to slow or stop the progression of Parkinson’s disease. VALBY, 12-Sep-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) begins clinical development of yet another potential new treatment of Parkinson’s disease with the enrollment of the … Read the full press release

AstraZeneca and Amgen announce US FDA Breakthrough Therapy Designation for tezepelumab in patients with severe asthma

AstraZeneca’s first Breakthrough Therapy Designation for a respiratory medicine Designation based on Phase IIb PATHWAY data that demonstrated tezepelumab significantly reduced asthma exacerbations compared to placebo in severe asthma CAMBRIDGE, 12-Sep-2018 — /EuropaWire/ — AstraZeneca and its partner Amgen Inc. (Amgen) … Read the full press release

Kuehne + Nagel deploys 35 new pharma trailers to strengthen its temperature-controlled overland services in Europe

Ensuring capacity for temperature-controlled overland services 35 new trailers facilitating intermodal KN PharmaChain connection SCHINDELLEGI, Switzerland, 05-Sep-2018 — /EuropaWire/ — With the ongoing market growth for temperature-controlled shipments, Kuehne + Nagel is investing in its European Pharma fleet to strengthen the … Read the full press release

Novartis announces EC approval for Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for adjuvant treatment of BRAF V600 mutation-positive melanoma

Approval based on COMBI-AD study demonstrating greater than 50% reduction in risk of disease recurrence or death in stage III melanoma patients   More than 50% of stage III melanoma patients are likely to recur to stage IV during their lifetime … Read the full press release

Alcon announces an immediate, voluntary market withdrawal of the CyPass Micro-Stent from the global market

Decision based on five-year data from COMPASS-XT long-term safety study Alcon advises ophthalmic surgeons to cease further implantation BASEL, 31-Aug-2018 — /EuropaWire/ — Reflecting its uncompromising commitment to patient safety, Alcon today announced an immediate, voluntary market withdrawal of the CyPass Micro-Stent from … Read the full press release

Philips on AI and adaptive intelligence in healthcare

AMSTERDAM, 31-Aug-2018 — /EuropaWire/ — At a time when health systems and healthcare professionals are under more pressure than ever to do more with less, the promise of intelligent technology that can deliver life-changing insights from all our data is … Read the full press release

Royal Philips to acquire US-based scale-up company developing and commercializing next-generation sensor technologies

AMSTERDAM, 31-Aug-2018 — /EuropaWire/ —  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired Xhale Assurance Inc, a US-based scale-up company developing and commercializing next-generation sensor technologies. Xhale Assurance’s unique, disposable pulse oximetry … Read the full press release

Royal Philips: the European Society of Cardiology to incorporate instantaneous wave-free ratio (iFR) into its updated revascularization guidelines

iFR-guided strategy now deemed beneficial in the assessment of the functional significance of intermediate coronary stenosis  Technique using iFR-guided strategy is non-inferior to FFR for guiding decisions for intervening on immediate lesions with stable angina or NSTE ACS MUNICH, 31-Aug-2018 … Read the full press release

Novartis: European Commission approval for Kymriah

The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell ALL and r/rDLBCL Novartis is the only company with an approved … Read the full press release

Novartis: the global Phase III SOLAR-1 trial evaluating the investigational alpha-specific PI3K inhibitor BYL719 has met the primary endpoint

SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on or following treatment with an aromatase inhibitor with or without a CDK4/6 inhibitor[1] Approximately 40% of HR+ advanced breast cancer … Read the full press release

Iain Mackay will be GSK’s next Chief Financial Officer (CFO); he also joins GSK Board

Brentford, United Kingdom, 14-Aug-2018 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Iain Mackay has been appointed GSK’s next Chief Financial Officer (CFO). He has also been appointed as an Executive Director to the GSK Board. Mr Mackay will … Read the full press release

Technical University of Munich scientists described a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid formation

MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer’s disease and type 2 diabetes are not yet available. Scientists at the Technical University of Munich (TUM) have now come a little bit closer to … Read the full press release

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announce European Commission approval for Rxulti® (brexpiprazole) for the treatment of schizophrenia in adults

Rxulti® (brexpiprazole) has been approved for the treatment of schizophrenia in adults. VALBY, 01-Aug-2018 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the European Commission has approved Rxulti® (brexpiprazole) for the treatment of schizophrenia … Read the full press release